Chargement en cours...
Immunotherapy in metastatic prostate cancer
INTRODUCTION: Prostate cancer remains a challenge as a target for immunological approaches. The approval of the first cell-based immune therapy, Sipuleucel-T for prostate cancer introduced prostate cancer as a solid tumor with the potential to be influenced by the immune system. METHODS: We reviewed...
Enregistré dans:
| Publié dans: | Indian J Urol |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5054656/ https://ncbi.nlm.nih.gov/pubmed/27843208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-1591.191240 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|